Main trends of immune effects triggered by nanomedicines in preclinical studies
Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann Directorate F-Health, Consumers and Reference Materials, European Commission Joint Research Centre (JRC), Ispra (VA), Italy Abstract: The application of nanotechnology to emerging medicinal products is a crucial parameter for the implementation of...
Saved in:
Main Authors: | Halamoda-Kenzaoui B, Bremer-Hoffmann S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/0b56e46c056e4b8399a74ddb452bae6a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
- Nanomedicine journal
- Journal of Interdisciplinary nanomedicine
- European journal of nanomedicine
-
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
by: Giannakou C, et al.
Published: (2016) -
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
by: Giulia Mitola, et al.
Published: (2021)